Alfentanil and fentanyl were compared as supplements to thiopentone, nitrous oxide, relaxant anaesthesia in a randomised, double blind trial carried out on 55 adult patients undergoing elective surgery. The fentanyl-treated patients resumed spontaneous ventilation more rapidly at the end of anaesthesia (3 minutes) than the alfentanil-treated group (5.1 minutes, p < 0.02). In other respects the drugs appeared indistinguishable. A computer model is used to explain why, despite the shorter elimination half-life, the alfentanil-treated patients did not awaken more rapidly than those in the fentanyl group.
were selected for the trial. Patients with severe intercurrent disease (ASA class 4 or worse) were excluded, as were patients who were possibly pregnant.
The anaesthetic technique used was modelled on the authors' normal clinical practice. The patients were all assessed the night prior to surgery and preoperative determinations of the full blood count (including differential white cell count), plasma electrolytes, urea, creatinine, bilirubin, alkaline phosphatase and alanine aminotransferase were ordered for the morning of the operation. The patients were medicated with 2 to 2.5 mg oral lorazepam about 2 hours prior to operation.
On arrival in the anaesthetic area an intravenous infusion of Hartmann's solution was commenced and the patients were connected to an electrocardiograph monitor with accurate heart rate display. A blood pressure cuff of suitable size was mounted for systolic and diastolic blood pressure determinations by auscultation at intervals of ten minutes or less. The patients were preoxygenated from a circle absorber system with im oxygen flow of 4 1 min -1 and anaesthesia was induced. The two opioids were made up for the trial in identical 5 ml ampoules containing either 250 I-Ig of fentanyl or 2500 I-Ig of alfentanil, that is 50 I-Ig and 500 I-Ig ml -1 respectively. Packs of four ampoules were made up for each patient, identified by a single code number. The concentrations of the drugs were chosen by the manufacturer (Janssen Pharmaceutica) based on supposed duration of action of alfentanil approximately one-third that of fentanyl and a similar ratio of their potencies. The objective was to make the use of the two drugs as similar as possible.
Anaesthesia was induced with an injection of 301-11 kg -1 of the trial drug, equivalent to 1.5 I-Ig kg -1 of fentanyl or 15 I-Ig kg -1 of alfentanil, followed by approximately 5 mg kg -1 thiopentone after which the dose of the trial drug was repeated, aiming to give the equivalent of 3 I-Ig kg -1 of fentanyl prior to intubation. This was followed by 100 I-Ig kg -1 pancuronium and tracheal intubation was performed. The gas mixture was then changed to nitrous oxide 4 1 min -1 and oxygen 2 1 min -1 for about ten minutes when the flows were halved. Ventilation was by positive pressure at a rate of 10 to 12 breaths min -I and a minute volume of about 70 ml kg -I. Anaesthesia was maintained with further 30 to 60 1-11 kg -1 aliquots of the trial drug and pancuronium as required. During the operation Hartmann's solution was administered at a rate of about 5 ml kg -1 hr -1. If there was significant blood loss extra intravenous fluid was given. When the final skin suture was inserted atropine and neostigmine were administered to reverse residual neuromuscular block. Three minutes later the nitrous oxide was turned off, oxygen flow increased to 3 1 min -1 and the circle absorber was excluded from the circuit. When spontaneous respiration had returned the patients were extubated and moved to the recovery area. If the respiration rate was less than 10 breaths per minute naloxone was administered, 100 to 200 I-Ig intravenously and the remainder of the 400 I-Ig ampoule intramuscularly.
Papaveretum 15 or 20 mg and prochlorperazine 12.5 mg by intramuscular injection were ordered for the patients on their return to the ward and these drugs were administered on demand at the discretion of the nursing staff who were not made aware of any special circumstances. All postoperative orders were according to the normal routine of the surgeon who performed the operation. The patients were followed up on the first two postoperative days by the anaesthetist and specifically questioned concerning nausea, vomiting and any urinary difficulties. On the second visit the blood count and biochemical investigations were repeated.
The following data were recorded for the study: demographic patient information including age, sex, height, and body weight. The usual preoperative history and examination was performed and all abnormal findings were noted as well as the patient's resting blood pressure. The patients were specifically questioned regarding allergies, adverse drug reactions and any medications which they were taking. An overall assessment in terms of the grading system of the American Society of Anesthesiologists was also recorded. 8 As discussed above, during induction and maintenance of anaesthesia vital signs were recorded frequently and in addition accurate records were kept of all drug administrations and intravenous fluids. At the termination of the anaesthetic the time elapsed from when the absorber and the nitrous oxide were turned off to the three indices of recovery (first spontaneous breath, opening eyes to command and the patient giving his or her name in response to a question) was recorded to the nearest minute. An assessment of the course of the anaesthetic was made -good, fair or poor -and any problems were recorded with special attention to the incidence of chest rigidity prior to intubation. The anaesthetic course was considered good if vital signs remained stable throughout; if hypertension greater than 201110 of control value occurred the course was classed as fair and if hypertension was greater than 50% of control or was accompanied by movement of the patient it was classed as poor. Hypotension or other problems were not encountered. On the postoperative visits on the two postoperative days the patients were questioned concerning nausea which was recorded as nil, slight, moderate or severe and vomiting, which was recorded as nil, once, several and severe. Difficulty in micturition or the need for bladder catheterisation was also noted.
Nominal and ordinal data were tabulated and tested for signi ficant di fference (p < 0.05) between the two drug groups by the Chi square test with Yates' correction for small groups where appropriate. Interval data were tested using Student's I-test for differences between the groups and the I-test for paired values for differences within patients (e.g. haemoglobin concentration before and after surgery). The statist ical operations were carried out using the Statistical Package for the Social Sciences. 9 
RESULTS
Demographic data for the two groups of patients (Table l) were not significantly different. Patients were deemed to have had significant drug therapy if they had been treated with cardiac active or liver enzymeinducing drugs. The patients' drug requirements are summarised in Table 2 to the fentanyl group was significantly more (p < 0.04). If, however, account is taken of the slightly longer average duration of the surgical procedures in this group and their slightly greater average bodyweight, the difference ceases to be significant. Chest rigidity at induction was noted in one patient in the alfentanil group and in three patients in the fentanyl group. This difference in incidence was not significant and clinically these patients presented no problems as the administration of pancuronium was followed by rapid resolution of the rigidity.
Neither the course of anaesthesia nor the incidence of postanaesthetic respiratory depression differed significantly in the two groups (Table 4) . Surprisingly, all three recovery parameters were achieved a little more rapidly in the fentanyl group (Table 3 ) and the difference in the time taken to commence spontaneous respiration was significant (p < 0.02). This finding will be discussed in some detail. Postoperative nausea was common, only five patients in the alfentanil group and 10 in the fentanyl group were free of it, although some patients who were noted to vomit in the early postoperative period did not recall any nausea when questioned later. These patients were classed among the 'slight' nausea group. About one-third of the patients in each group experienced moderate or severe nausea. About half the patients vomited at some time, but only one patient was severely affected and she was unable to tolerate oral intake until late on the second postoperative day. The incidence of the need for urinary catheterisation after operation was also similar in the two groups. Ten and nine patients respectively for alfentanil and fentanyl received no parenteral analgesics. For the others the average interval from operation to first injection was 279 and 309 minutes respectively, with a wide scatter ( Table 5 ). The average number of doses of parenteral analgesic was also very similar in the two groups as was the number of administrations of the antiemetic prochlorperazine which was available for all patients in the study. As a generalisation the two drugs behaved clinically indistinguishably under the conditions of the study. The haematological data from the patients is -Indicates statistically significant (p < 0.05) difference between the pre-and postoperative values. Significant differences between the two groups were not found.
Mean preoperative and postoperative haematological values with standard deviations [or the two patient groups
summarised in Table 6 and the biochemical data in Table 7 . Although the preoperative white cell count and lymphocyte count differ significantly between the two groups, we attach no special significance to this. The differences between pre-and postoperative values are in line with those expected following operations, e.g. fall in haemoglobin concentration, leukocytosis and lymphopoenia. The biochemical changes tend to reflect the postoperative fluid regime, which was based on 2 to 3 litres of 4070 dextrose in 0.18070 saline intravenously, and early oral intake, where possible.
DISCUSSION
This study demonstrates a number of points in comparing alfentanil with the commonly used narcotic anaesthetic adjuvant, fentanyl, but it is important to define first the limitations of the study. The subjects were adult patients, with the old (over 65 years) and the severely ill excluded. Equally important is the fact that neither very short nor very long procedures were included. The shortest anaesthetic in the study was 40 minutes, and only one exceeded 3 hours, at 3 hours 40 minutes duration. Third, the waking parameters chosen corresponded more with 'recovery room safe' state, rather than any measure of full recovery, as would be evidenced by complex task or psychometric tests. It is safe to assume that our patients still had significant plasma concentrations of narcotic present even when the third parameter of awakening (answers questions) was fulfilled. Finally it must be noted that the total quantity of opiate used (average about 5 mg alfentanil or 600 JAg fentanyl) over the average case duration of two hours may differ from other studies.
Bearing in mind these limits, the obvious conclusion is that the two drugs did not differ in any clinically significant way. Although among the haematological and biochemical results some differences emerged, we do not believe them to be clinically meaningful. The 'before and after' differences reflect the known effects of operation and probably the nature of the postoperative fluid management, as discussed above. The anaesthetic parameters were by and large very similar in the two groups. Nor was the incidence of postoperative respiratory depression (rate less than 10 per minute) significantly different. Contrary to previous reports, the incidence of chest rigidity was no higher following alfentanil than in the fentanyl group. We ascribe the relatively low incidence 7 to the manner in which anaesthesia was induced, avoiding large bolus doses of the narcotics.
The unexpected finding in this study concerned the awakening parameters. Surprisingly, the patients who received alfentanil failed to wake up more rapidly than those who were treated with fentanyl. In fact the latter group took significantly less time to resume spontaneous ventilation than the alfentanil group (Table 3 ). In view of the statements in the literature concerning the short-acting nature of alfentanil, this required explanation. To elucidate this a computer model comparing the pharmacokinetics of the two drugs was set up to see whether this was simply due to the relatively large dose of alfentanil used and whether the kinetics of the drugs would predict under what circumstances alfentanil could be expected to behave as a short-acting drug.
Computer model
A model was devised using pharmacokinetic data available for the two drugs 4 to calculate the plasma concentration following repeated intravenous injections. A 'standard' dosage schedule was set up, resembling our clinical practice. The initial dose of alfentanil or fentanyl was set at 2000 and 200 JAg respectively and this was subtracted from the average total opiate doses used, 4950 and 580 JAg. The remaining quantity of drug was divided into 5 equal doses, rounded to 600 and 80 JAg respectively and 'administered ' 10, 20, 30, 60 and 90 minutes after the initial dose, corresponding to clinical practice. As we concluded that the effects of the two drugs were similar in intensity, the plasma concentration of fentanyl was multiplied by a factor of 75 to superimpose the two concentration-time curves. This factor corresponds well with that used by Stanski and Hug (50-100) to compare the therapeutic levels of the two drugs,1O albeit the figures of Shafer et al. 11 suggest a factor of 20 to 30. In the first model, the plasma drug concentrations following the two opiates was plotted out at I-minute intervals for 4 hours (Figure 1) . A second, similar model was set up to simulate a longer anaesthetic, by the administration of three further standard doses of narcotic, at 135, 180 and 240 minutes. The hypothetical plasma concentrations were then calculated and plotted for 8 hours (Figure 2) .
From these models a number of conclusions can be drawn. The 'rapid phase' half-lives of the two drugs are 4.6 minutes for fentanyl and 6.6 for alfentanil. This is evident in the steepness of the initial downslope of the concentration curve after each 'injection'. The shorter elimination half-life of alfentanil, on the other hand, is reflected in its lack of cumulation, best seen in Figure 2 . The models suggest that smooth induction with alfentanil could be accomplished with somewhat smaller doses than were used. With the dosage schedule used in the models, at 2 hours (approximate average duration of our cases) there is little difference in the effective plasma concentration of the two drugs. If this is the concentration which corresponds to our awakening parameters, then the model predicts that there should be little difference between the two patient groups in this regard. If recovery parameters are used which demand much lower plasma drug concentrations, such as complex psychometric tests or tests of co-ordination, the model predicts that this will be reached much sooner in patients given alfentanil than those anaesthetised with fentanyl. At least one study has confirmed this.12 The second model, corresponding to longer anaesthesia, suggests that with the dosage schedule employed, the critical time is about 2 hours, beyond which the parameters used in this study will favour the alfentanil group, as regards the rate of awakening.
It is interesting to draw the analogy between thiopentone and these drugs. Twenty years ago, Green et al. 13 demonstrated that although the time taken to wake up following methohexitone did not differ from that following thiopentone, the ability to perform complex tasks (driving simulation in that study) was regained significantly sooner following the former drug. We now know that, of the two, thiopentone has the much longer elimination half-life, although its redistribution half-life is shorter than that of methohexitone. The situation is analogous to the two drugs in this study and the computed models illustrate the relations well. The elimination half-life cannot be used to predict the speed of recovery by itself, especially while moderate doses are used. The models explain our failure to demonstrate more rapid awakening after alfentanil than fentanyl and predict, however, that awakening following alfentanil will be more rapid than after fentanyl if large total doses are administered and also suggest that clear mentation will follow alfentanil more rapidly than fentanyl.
